RWHCblog

This week's article about the side effects of treatment for acute lymphoblastic leukemia (ALL) is excerpted from @CancerSupportHQ's Frankly Speaking About Cancer series. bit.ly/3wsijUN

Thank you to Dr. Busby-Whitehead for sitting down with us to discuss the important resources HiAF provides to the Alzheimer's and dementia community. Read the article here: healthwellfoundation.org/realworldhealt…

If you or someone you love has Alzheimer's disease, how do you know which treatments will truly help slow the decline? Learn about a trusted source for Alzheimer's information, @HealthInAging, in this week's blog: bit.ly/3PhWhuv

With unique insights into issues facing underrepresented patient populations, the Association of Community Cancer Centers (@ACCCBuzz) recently developed consensus-driven recommendations to improve diversity, equity & accessibility in cancer research. bit.ly/39xi8iE

Alzheimer’s disease is a leading cause of death in the U.S., and affects millions of Americans. It’s important to distinguish the facts from the myths about Alzheimer’s, especially when it comes to finding information online. Learn more: bit.ly/3t3FK4e

Did you know that Acute Lymphoblastic Leukemia (ALL) is the most common type of cancer in children? Learn more about ALL and whom it affects in our most recent blog: bit.ly/34oiN3t

Our Managing Editor, Linda Barlow, recently spoke with @HealthWellOrg President, Krista Zodet, about how HealthWell and other non-profits remained unwavering in their commitment to assisting those in need during one of the most challenging recent years. bit.ly/3ywggi0

The @CllSociety understands that a diagnosis of chronic lymphocytic leukemia (CLL) can be overwhelming, but the right care can make all the difference. Read more about options available to you in this week's Real World Health Care blog: bit.ly/3hvxViL

If you've been newly diagnosed with Chronic Lymphocytic Leukemia (CLL), you may be wondering what comes next. Read our latest @RWHCblog for the basics on CLL, treatment options and advice from @CancerSupportHQ on what questions to ask your care team. bit.ly/3y002vE

How much do you know about Acute Myeloid Leukemia? Learn the basics with us in the latest edition of our blog. bit.ly/3CeLETR

To improve early identification & management of Sjögren's-related pulmonary complications, @SjogrensOrg led development of a new set of clinical practice guidelines. We discuss the guidelines with two of their key architects in the latest blog: bit.ly/3hscmjq

This month, we're focusing on Hepatitis C! In this article, we'll shine a spotlight on two organizations committed to serving the hepatitis C community: National Viral Hepatitis Roundtable (@NVHR1) and Community Liver Alliance (@CLA_Pitt.) bit.ly/3bmb2uR

This week's blog post features trusted COVID-19 resources from four government agencies. These are among the most reliable sources of COVID-19 information and should be among your go-to resources when you need information on the pandemic. bit.ly/2MpvmSB

Read the first blog post of 2021 from @RWHCblog, penned by Krista Zodet, President of @HealthWellOrg, here: bit.ly/3iheWYv

@DeptVetAffairs & @ParkinsonDotOrg teamed up to improve the health, well-being & quality of life of veterans living w Parkinson’s disease. Read what Ronnie Todaro, Exec VP & COO of the Parkinson's Foundation, says about the initiative in this week's blog.

This week we speak with Matthew Capriotti, PhD, assoc prof of Psych @SJSU, about the role of Comprehensive Behavioral Intervention for Tics (CBIT) & his work with Treating Tourette Together, a collab between @TouretteAssn, @PCORI & leading researchers. bit.ly/2GnttTE

It's Prostate Cancer Awareness Month, & we'd like to thank @ZEROCancer's Board Chairman, Robert Ginyard, & Dr. Kelvin Moses, Assoc Prof of Urology, @VanderbiltU for reminding us that prostate cancer disproportionately affects Black patients. Read more: bit.ly/2RGBTI6.

Read our recent interview w/ @theMMRF's Anne Quinn Young, MPH, CMDO & Hearn Jay Cho, MD, PhD, CMO, about the potential of CAR-T therapy & how MMRF supports research on individualized targeted therapies for multiple myeloma patients. bit.ly/2DMZeDW

This week, we are sharing the inspirational story of Robyn Stacy-Humphries, MD, a woman who was diagnosed with lymphoma at 48 years old and received treatment with CAR T-cell therapy. Read about her journey here: bit.ly/3hyrMjs.

#DYK about 1 in 10 adults who take certain forms of antipsychotics eventually develop a movement disorder called Tardive Dyskinesia? Learn more in our latest blog post. Patrick Hendry, VP of Peer Advocacy, Supports and Services for @MentalHealthAm: bit.ly/3236x4y.